Kindstar Globalgene Technology, Inc. repurchased 43,000 ordinary shares on 2 September 2026 through on-market transactions on the Hong Kong Stock Exchange. The shares were bought at prices ranging from HKD 0.975 to HKD 1.000, for a total consideration of HKD 42,664.60, or an average HKD 0.9922 per share.

The transaction reduced the company’s outstanding share count by 0.00416 %, bringing issued shares (excluding treasury shares) to 1.03261 billion. Concurrently, treasury shares increased from 8.68 million to 8.72 million.

The buyback forms part of the mandate approved on 5 June 2026, which authorises up to 103.43 million shares for repurchase. Cumulative repurchases under this mandate now total 1.66 million shares, equivalent to 0.16011 % of the issued share capital on the mandate approval date.

A 30-day moratorium on new share issues or further treasury-share disposals runs until 2 October 2026, in accordance with Hong Kong listing rules.